Viridian Therapeutics Inc - VRDN - stock price prediction, stock price target, analyst ratings from 17 analysts

Viridian Therapeutics Inc has a share price target of US$ 34, revenue growth forecast of -52.5%, and profit growth estimate of -27.9% for FY26, based on top 17 analyst calls.